SMO CLINPLUS CO LTSMO CLINPLUS CO LTSMO CLINPLUS CO LT

SMO CLINPLUS CO LT

No trades
See on Supercharts
Market capitalization
‪2.10 B‬CNY
1.34CNY
‪134.73 M‬CNY
‪754.56 M‬CNY
Beta (1Y)
1.81
Employees (FY)
‪4.19 K‬
Change (1Y)
+548 +15.06%
Revenue / Employee (1Y)
‪180.26 K‬CNY
Net income / Employee (1Y)
‪32.19 K‬CNY

About SMO CLINPLUS CO LT


CEO
Hong Wei Yang
Headquarters
Shanghai
Founded
2009
ISIN
CNE100005CP8
FIGI
BBG00XVCGVL7
SMO ClinPlus Co., Ltd. provides site management organization (SMO) services for clinical research and development. It offers launch planning and feasibility surveys, site startup, on-site execution, and project management services. The company was founded by Hong Wei Yang in 2009 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 301257 is 26.36 CNY — it has decreased by −0.45% in the past 24 hours. Watch SMO CLINPLUS CO LT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange SMO CLINPLUS CO LT stocks are traded under the ticker 301257.
301257 stock has risen by 0.80% compared to the previous week, the month change is a −6.86% fall, over the last year SMO CLINPLUS CO LT has showed a −28.55% decrease.
301257 reached its all-time high on Apr 28, 2023 with the price of 65.85 CNY, and its all-time low was 23.07 CNY and was reached on Aug 28, 2024. View more price dynamics on 301257 chart.
See other stocks reaching their highest and lowest prices.
301257 stock is 2.01% volatile and has beta coefficient of 1.81. Track SMO CLINPLUS CO LT stock price on the chart and check out the list of the most volatile stocks — is SMO CLINPLUS CO LT there?
Today SMO CLINPLUS CO LT has the market capitalization of ‪2.10 B‬, it has increased by 0.61% over the last week.
Yes, you can track SMO CLINPLUS CO LT financials in yearly and quarterly reports right on TradingView.
301257 net income for the last quarter is ‪17.34 M‬ CNY, while the quarter before that showed ‪32.19 M‬ CNY of net income which accounts for −46.12% change. Track more SMO CLINPLUS CO LT financial stats to get the full picture.
SMO CLINPLUS CO LT dividend yield was 0.28% in 2023, and payout ratio reached 8.17%. The year before the numbers were 0.23% and 9.09% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 30, 2025, the company has ‪4.19 K‬ employees. See our rating of the largest employees — is SMO CLINPLUS CO LT on this list?
Like other stocks, 301257 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SMO CLINPLUS CO LT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SMO CLINPLUS CO LT technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SMO CLINPLUS CO LT stock shows the strong sell signal. See more of SMO CLINPLUS CO LT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.